Bank of New York Mellon’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Buy
103,773
+13,788
+15% +$156K ﹤0.01% 3036
2025
Q1
$598K Sell
89,985
-3,210
-3% -$21.3K ﹤0.01% 3339
2024
Q4
$1.03M Buy
93,195
+1,330
+1% +$14.7K ﹤0.01% 3131
2024
Q3
$1.13M Sell
91,865
-24,027
-21% -$295K ﹤0.01% 3066
2024
Q2
$1.57M Buy
115,892
+25,988
+29% +$351K ﹤0.01% 2936
2024
Q1
$1.21M Sell
89,904
-8,424
-9% -$114K ﹤0.01% 3040
2023
Q4
$517K Sell
98,328
-8,926
-8% -$47K ﹤0.01% 3529
2023
Q3
$423K Buy
107,254
+2,926
+3% +$11.5K ﹤0.01% 3635
2023
Q2
$1.11M Buy
104,328
+14,746
+16% +$157K ﹤0.01% 3133
2023
Q1
$746K Sell
89,582
-1,193
-1% -$9.94K ﹤0.01% 3269
2022
Q4
$838K Buy
90,775
+10,595
+13% +$97.8K ﹤0.01% 3278
2022
Q3
$1.03M Buy
80,180
+8,556
+12% +$110K ﹤0.01% 3188
2022
Q2
$947K Buy
71,624
+8,926
+14% +$118K ﹤0.01% 3239
2022
Q1
$1.32M Buy
62,698
+837
+1% +$17.6K ﹤0.01% 3142
2021
Q4
$1.48M Buy
61,861
+1,924
+3% +$46.2K ﹤0.01% 3158
2021
Q3
$1.53M Buy
59,937
+5,565
+10% +$142K ﹤0.01% 3161
2021
Q2
$1.83M Buy
54,372
+3,192
+6% +$107K ﹤0.01% 3038
2021
Q1
$1.99M Sell
51,180
-3,055
-6% -$119K ﹤0.01% 2926
2020
Q4
$3.36M Buy
54,235
+5,281
+11% +$327K ﹤0.01% 2541
2020
Q3
$1.64M Sell
48,954
-2,090
-4% -$70K ﹤0.01% 2780
2020
Q2
$1.22M Sell
51,044
-6,218
-11% -$148K ﹤0.01% 2984
2020
Q1
$1.31M Buy
57,262
+23,581
+70% +$540K ﹤0.01% 2785
2019
Q4
$954K Buy
33,681
+9,086
+37% +$257K ﹤0.01% 3268
2019
Q3
$529K Buy
+24,595
New +$529K ﹤0.01% 3500